HCWB: HCW Biologics Inc. Stock

by  •  • Comments Off on HCWB: HCW Biologics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 8.57
Enterprise Value ($M) 17.72
Book Value ($M) -6.77
Book Value / Share -6.03
Price / Book -1.27
NCAV ($M) -31.31
NCAV / Share -27.87
Price / NCAV -0.27

Profitability (mra)
Return on Invested Capital (ROIC) -4.26
Return on Assets (ROA) -0.99
Return on Equity (ROE) -3.43

Liquidity (mrq)
Quick Ratio 0.19
Current Ratio 0.19

Balance Sheet (mrq) ($M)
Current Assets 5.70
Assets 30.24
Liabilities 37.01
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2.57
Operating Income -29.48
Net Income -30.02

Cash Flow Statement (mra) ($M)
Cash From Operations -14.23
Cash from Investing -0.26
Cash from Financing 15.57

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-22 13D/A Wong Hing C 36.04

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-15 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 6,271 28,329 22.14
2025-04-16 992 3,480 28.51
2025-04-15 2,994 10,109 29.62

(click for more detail)

Similar Companies
GRCE – Grace Therapeutics, Inc. GTBP – GT Biopharma, Inc.
GYRE – Gyre Therapeutics, Inc. HEPA – Hepion Pharmaceuticals, Inc.
HOOK – HOOKIPA Pharma Inc.


Financial data and stock pages provided by
Fintel.io